What Researchers Did
Researchers conducted a literature review to evaluate the current evidence regarding hyperbaric oxygen therapy (HBOT) as a complementary treatment for radiation proctitis (RP).
What They Found
The review found that despite a large therapeutic armamentarium for radiation proctitis (RP), the evidence regarding the impact and benefits of hyperbaric oxygen therapy (HBOT) remains conflicting. The authors highlighted the need for additional prospective and randomized studies to validate HBOT's effectiveness in clinical practice.
What This Means for Canadian Patients
Canadian patients experiencing radiation proctitis after cancer treatment may encounter conflicting information regarding the effectiveness of hyperbaric oxygen therapy (HBOT). Given the current uncertainty, treatment decisions should be made in consultation with their healthcare team, considering all available evidence and individual circumstances.
Canadian Relevance
This study has no direct Canadian connection as it is a literature review without specific geographic focus on Canada.
Study Limitations
As a literature review, this study's findings are limited by the quality and heterogeneity of the existing evidence on hyperbaric oxygen therapy for radiation proctitis, which the authors themselves describe as conflicting.